nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A complicated case of metastatic teratoma
|
Simmonds, P.D. |
|
|
6 |
2 |
p. 181-185 |
artikel |
2 |
Ambulatory 4-day continuous-infusion schedule of high-dose ifosfamide with mesna uroprotection and granulocyte colony-stimulating factor in advanced solid tumours: A phase I study
|
Toma, S. |
|
|
6 |
2 |
p. 193-196 |
artikel |
3 |
…and funding for cancer research must be transparent
|
|
|
|
6 |
2 |
p. 99 |
artikel |
4 |
A phase II trial of vinorelbine and thiotepa in metastatic breast cancer
|
Fabi, A. |
|
|
6 |
2 |
p. 187-189 |
artikel |
5 |
Bickering between the NCI and NSABP
|
|
|
|
6 |
2 |
p. 97 |
artikel |
6 |
Book review
|
Cavalli, F. |
|
|
6 |
2 |
p. 101 |
artikel |
7 |
Book review
|
Weber, Walter |
|
|
6 |
2 |
p. 108 |
artikel |
8 |
Book review
|
Ghielmini, M. |
|
|
6 |
2 |
p. 189 |
artikel |
9 |
Book review
|
Bernhard, Jürg |
|
|
6 |
2 |
p. 112 |
artikel |
10 |
ChlVPP therapy for Hodgkin's disease: Experience of 960 patients
|
|
|
|
6 |
2 |
p. 167-172 |
artikel |
11 |
Combination 5-fluorouracil (FU), folinic acid (FA), and α-interferon 2B in advanced gastric cancer: Results of a phase II trial
|
Jäger, E. |
|
|
6 |
2 |
p. 153-156 |
artikel |
12 |
Comment on the letter from Fuchsberger and Lakota
|
Gianni, A.M. |
|
|
6 |
2 |
p. 198 |
artikel |
13 |
Contents of the next issue
|
|
|
|
6 |
2 |
p. 96 |
artikel |
14 |
Copyright
|
|
|
|
6 |
2 |
p. ii |
artikel |
15 |
Critique of the critique: Response to the editorial entitled ‘Classification of Lymphoid Neoplasms’ by Dr. Saul Rosenberg which accompanied the publication of the ‘Revised European-American Lymphoma Classification Proposal’ in the September 1994 issue of Blood
|
Stein, H. |
|
|
6 |
2 |
p. 109-111 |
artikel |
16 |
Current position of vinorelbine in cancer chemotherapy
|
Sørensen, JensBenn |
|
|
6 |
2 |
p. 105-107 |
artikel |
17 |
Early versus late alternating chemotherapy in small-cell lung cancer
|
Joss, R.A. |
|
|
6 |
2 |
p. 157-166 |
artikel |
18 |
ESMO Lisbon: Success cum “cliff hanger”
|
|
|
|
6 |
2 |
p. 99-100 |
artikel |
19 |
French minister: “We badly need a cancer plan…”
|
|
|
|
6 |
2 |
p. 99 |
artikel |
20 |
High-dose chemotherapy and autologous peripheral stem cell transplantation in patients with relapsing malignant lymphomas – first experience in the Slovak Republic
|
Fuchsberger, P. |
|
|
6 |
2 |
p. 197-198 |
artikel |
21 |
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease
|
Salvagno, L. |
|
|
6 |
2 |
p. 173-179 |
artikel |
22 |
In this issue
|
|
|
|
6 |
2 |
p. 96 |
artikel |
23 |
Krakoff has bad luck in Scotland
|
|
|
|
6 |
2 |
p. 98-99 |
artikel |
24 |
Oregon approves assisted suicide measures
|
|
|
|
6 |
2 |
p. 97 |
artikel |
25 |
Perhaps not everyone knows that…
|
|
|
|
6 |
2 |
p. 100-101 |
artikel |
26 |
Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors*
|
Catimel, G. |
|
|
6 |
2 |
p. 133-140 |
artikel |
27 |
Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study
|
Wagener, D.J.Th. |
|
|
6 |
2 |
p. 129-132 |
artikel |
28 |
Phase I study of weekly high-dose cisplatin combined with long-term oral etoposide in advanced solid tumors
|
Planting, A.S.T. |
|
|
6 |
2 |
p. 190-192 |
artikel |
29 |
Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials*
|
Chabot, G.G. |
|
|
6 |
2 |
p. 141-151 |
artikel |
30 |
Professor Federico Calabresi
|
Cognetti, Francesco |
|
|
6 |
2 |
p. 95 |
artikel |
31 |
Survey on euthanasia in Britain
|
|
|
|
6 |
2 |
p. 97-98 |
artikel |
32 |
Table of Contents
|
|
|
|
6 |
2 |
p. i-ii |
artikel |
33 |
Tamoxifen chemoprevention: Public health goals, toxicities for all and benefits to a few
|
Love, R.R. |
|
|
6 |
2 |
p. 127-128 |
artikel |
34 |
The treatment of advanced bladder cancer
|
Sternberg, C.N. |
|
|
6 |
2 |
p. 113-126 |
artikel |
35 |
Topoisomerase I inhibition: A new target or new missiles?
|
Verweij, J. |
|
|
6 |
2 |
p. 102-104 |
artikel |